Beyond Phecodes: leveraging PheMAP to identify patients lacking diagnosis codes in electronic health records.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: phenotypes of interest
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Excluding Possibly Positive cases, the precision for T2DM and prostate cancer was 88.9% and 81.3%, respectively. [CONCLUSIONS] Leveraging clinical terminologies incorporated by PheMAP can effectively identify patients with phenotypes who lack EHR diagnosis codes, thereby enhancing phenotyping quality and related research reliability.
[OBJECTIVE] Diagnosis codes documented in electronic health records (EHR) are often relied upon to clinically phenotype patients for biomedical research.
APA
Yan C, Grabowska ME, et al. (2025). Beyond Phecodes: leveraging PheMAP to identify patients lacking diagnosis codes in electronic health records.. Journal of the American Medical Informatics Association : JAMIA, 32(6), 1007-1014. https://doi.org/10.1093/jamia/ocaf055
MLA
Yan C, et al.. "Beyond Phecodes: leveraging PheMAP to identify patients lacking diagnosis codes in electronic health records.." Journal of the American Medical Informatics Association : JAMIA, vol. 32, no. 6, 2025, pp. 1007-1014.
PMID
40156924 ↗
Abstract 한글 요약
[OBJECTIVE] Diagnosis codes documented in electronic health records (EHR) are often relied upon to clinically phenotype patients for biomedical research. However, these diagnoses can be incomplete and inaccurate, leading to false negatives when searching for patients with phenotypes of interest. This study aims to determine whether PheMAP, a comprehensive knowledgebase integrating multiple clinical terminologies beyond diagnosis to capture phenotypes, can effectively identify patients lacking relevant EHR diagnosis codes.
[MATERIALS AND METHODS] We investigated a collection of 3.5 million patient records from Vanderbilt University Medical Center's EHR and focused on 4 well-studied phenotypes: (1) type 2 diabetes mellitus (T2DM), (2) dementia, (3) prostate cancer, and (4) sensorineural hearing loss. We applied PheMAP to match structured concepts in patient records and calculated a phenotype risk score (PheScore) to indicate patient-phenotype similarity. Patients meeting predefined PheScore criteria but lacking diagnosis codes were identified. Clinically knowledgeable experts adjudicated randomly selected patients per phenotype as Positive, Possibly Positive, or Negative.
[RESULTS] Our approach indicated that 5.3% of patients lacked a diagnosis for T2DM, 4.5% for dementia, 2.2% for prostate cancer, and 0.2% for sensorineural hearing loss. The expert review indicated 100% precision (for Possibly Positive or Positive cases) for dementia and sensorineural hearing loss, and 90.0% and 85.0% precision for T2DM and prostate cancer, respectively. Excluding Possibly Positive cases, the precision for T2DM and prostate cancer was 88.9% and 81.3%, respectively.
[CONCLUSIONS] Leveraging clinical terminologies incorporated by PheMAP can effectively identify patients with phenotypes who lack EHR diagnosis codes, thereby enhancing phenotyping quality and related research reliability.
[MATERIALS AND METHODS] We investigated a collection of 3.5 million patient records from Vanderbilt University Medical Center's EHR and focused on 4 well-studied phenotypes: (1) type 2 diabetes mellitus (T2DM), (2) dementia, (3) prostate cancer, and (4) sensorineural hearing loss. We applied PheMAP to match structured concepts in patient records and calculated a phenotype risk score (PheScore) to indicate patient-phenotype similarity. Patients meeting predefined PheScore criteria but lacking diagnosis codes were identified. Clinically knowledgeable experts adjudicated randomly selected patients per phenotype as Positive, Possibly Positive, or Negative.
[RESULTS] Our approach indicated that 5.3% of patients lacked a diagnosis for T2DM, 4.5% for dementia, 2.2% for prostate cancer, and 0.2% for sensorineural hearing loss. The expert review indicated 100% precision (for Possibly Positive or Positive cases) for dementia and sensorineural hearing loss, and 90.0% and 85.0% precision for T2DM and prostate cancer, respectively. Excluding Possibly Positive cases, the precision for T2DM and prostate cancer was 88.9% and 81.3%, respectively.
[CONCLUSIONS] Leveraging clinical terminologies incorporated by PheMAP can effectively identify patients with phenotypes who lack EHR diagnosis codes, thereby enhancing phenotyping quality and related research reliability.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- [Strategies for the prevention and treatment of peritoneal metastases in large Borrmann type III and type IV gastric cancer].
- Predicting MammaPrint Recurrence Risk from Breast Cancer Pathological Images Using a Weakly Supervised Transformer.
- Utility of 3D Imaging in the Objective Evaluation of Glabellar Lines Following Botulinum Toxin Treatment.
- Single-cell RNA sequencing dissect the immunological network of immune checkpoint inhibitors-induced myocarditis.
- RAS/MEK/PI3K pathway inhibition augments response to CD40 agonism by targeting CD11b Bregs thereby overcoming melanoma PD1-resistance.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.